Mitchell S. Kapoor
Stock Analyst at HC Wainwright & Co.
(4.82)
# 996
Out of 5,182 analysts
98
Total ratings
68.54%
Success rate
28.21%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell S. Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KYTX Kyverna Therapeutics | Reiterates: Buy | $20 | $8.99 | +122.47% | 3 | Apr 23, 2026 | |
| IPSC Century Therapeutics | Maintains: Buy | $2 → $5 | $2.25 | +122.22% | 1 | Apr 21, 2026 | |
| LEGN Legend Biotech | Reiterates: Buy | $50 | $23.65 | +111.42% | 4 | Apr 21, 2026 | |
| SRPT Sarepta Therapeutics | Reiterates: Sell | $5 | $20.98 | -76.17% | 5 | Apr 16, 2026 | |
| INCY Incyte | Reiterates: Buy | $135 | $95.72 | +41.04% | 6 | Apr 15, 2026 | |
| ORKA Oruka Therapeutics | Maintains: Buy | $40 → $70 | $76.39 | -8.36% | 3 | Apr 13, 2026 | |
| GENB Generate Biomedicines | Initiates: Buy | $16 | $12.45 | +28.51% | 1 | Apr 13, 2026 | |
| ALMS Alumis | Maintains: Buy | $40 → $25 | $24.75 | +1.01% | 4 | Mar 30, 2026 | |
| PALI Palisade Bio | Initiates: Buy | $7 | $1.96 | +257.14% | 1 | Mar 26, 2026 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $110 → $120 | $72.23 | +66.14% | 7 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $40 | $14.42 | +177.39% | 3 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $50 | $25.00 | +100.00% | 3 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $17 | $4.29 | +296.27% | 2 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $30 | $13.04 | +130.06% | 7 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $22 | $25.15 | -12.52% | 3 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $55 | $53.81 | +2.22% | 5 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $30 | $22.12 | +35.62% | 8 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $45 | $36.92 | +21.89% | 2 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $20 | $12.84 | +55.76% | 3 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $27.05 | +158.78% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $5.63 | +77.78% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.13 | - | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $64.49 | +39.56% | 5 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $20 → $45 | $22.77 | +97.63% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $9.13 | +119.06% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $30 | $7.07 | +324.33% | 1 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $50.99 | +56.89% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.89 | +73.01% | 2 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.49 | +371.38% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 → $2 | $5.41 | -63.03% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.47 | +172.11% | 1 | Aug 11, 2025 |
Kyverna Therapeutics
Apr 23, 2026
Reiterates: Buy
Price Target: $20
Current: $8.99
Upside: +122.47%
Century Therapeutics
Apr 21, 2026
Maintains: Buy
Price Target: $2 → $5
Current: $2.25
Upside: +122.22%
Legend Biotech
Apr 21, 2026
Reiterates: Buy
Price Target: $50
Current: $23.65
Upside: +111.42%
Sarepta Therapeutics
Apr 16, 2026
Reiterates: Sell
Price Target: $5
Current: $20.98
Upside: -76.17%
Incyte
Apr 15, 2026
Reiterates: Buy
Price Target: $135
Current: $95.72
Upside: +41.04%
Oruka Therapeutics
Apr 13, 2026
Maintains: Buy
Price Target: $40 → $70
Current: $76.39
Upside: -8.36%
Generate Biomedicines
Apr 13, 2026
Initiates: Buy
Price Target: $16
Current: $12.45
Upside: +28.51%
Alumis
Mar 30, 2026
Maintains: Buy
Price Target: $40 → $25
Current: $24.75
Upside: +1.01%
Palisade Bio
Mar 26, 2026
Initiates: Buy
Price Target: $7
Current: $1.96
Upside: +257.14%
Ionis Pharmaceuticals
Mar 25, 2026
Maintains: Buy
Price Target: $110 → $120
Current: $72.23
Upside: +66.14%
Mar 25, 2026
Maintains: Buy
Price Target: $25 → $40
Current: $14.42
Upside: +177.39%
Mar 18, 2026
Maintains: Buy
Price Target: $65 → $50
Current: $25.00
Upside: +100.00%
Mar 16, 2026
Maintains: Buy
Price Target: $10 → $17
Current: $4.29
Upside: +296.27%
Mar 3, 2026
Maintains: Buy
Price Target: $25 → $30
Current: $13.04
Upside: +130.06%
Mar 2, 2026
Maintains: Buy
Price Target: $25 → $22
Current: $25.15
Upside: -12.52%
Mar 2, 2026
Reiterates: Neutral
Price Target: $55
Current: $53.81
Upside: +2.22%
Feb 24, 2026
Maintains: Buy
Price Target: $40 → $30
Current: $22.12
Upside: +35.62%
Feb 17, 2026
Maintains: Buy
Price Target: $30 → $45
Current: $36.92
Upside: +21.89%
Jan 29, 2026
Upgrades: Buy
Price Target: $20
Current: $12.84
Upside: +55.76%
Jan 13, 2026
Reiterates: Buy
Price Target: $70
Current: $27.05
Upside: +158.78%
Jan 13, 2026
Maintains: Buy
Price Target: $13 → $10
Current: $5.63
Upside: +77.78%
Jan 7, 2026
Downgrades: Neutral
Price Target: n/a
Current: $8.13
Upside: -
Dec 19, 2025
Reiterates: Buy
Price Target: $90
Current: $64.49
Upside: +39.56%
Dec 9, 2025
Upgrades: Buy
Price Target: $20 → $45
Current: $22.77
Upside: +97.63%
Nov 24, 2025
Initiates: Buy
Price Target: $20
Current: $9.13
Upside: +119.06%
Nov 19, 2025
Maintains: Buy
Price Target: $40 → $30
Current: $7.07
Upside: +324.33%
Sep 23, 2025
Reiterates: Buy
Price Target: $80
Current: $50.99
Upside: +56.89%
Sep 5, 2025
Reiterates: Buy
Price Target: $5
Current: $2.89
Upside: +73.01%
Aug 19, 2025
Reiterates: Buy
Price Target: $7
Current: $1.49
Upside: +371.38%
Aug 19, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $5.41
Upside: -63.03%
Aug 11, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.47
Upside: +172.11%